Q1 2026 Credit Markets Retrospective and Q2 Forward View

Private credit deployment ran at $89B inQ1 2026, up 34% from Q1 2025 (PitchBook H1 2026 Private Credit). Spreadscompressed 85 basis points against SOFR while covenant packages loosened in thetop quartile of deals. The question for Q2 is whether the compression continuesor the cycle turns.

WhatQ1 actually did

Direct lendingfunds deployed $89B into US middle-market credits in Q1 2026, thesecond-highest quarterly figure on record (PitchBook H1 2026 Private Credit).The volume alone would suggest a healthy market. The spread and structure datasuggest something else. Weighted average spreads on new-issue unitranchefacilities compressed to SOFR plus 525 basis points, down from SOFR plus 610 inQ1 2025 (S&P LCD US Loan Comparable, March 2026 print).

Covenant erosiontracked the spread compression. Cooley GO's Q1 2026 Venture Debt survey shows61% of growth-stage debt facilities closed in the quarter carried covenant-liteor covenant-loose structures, against 44% one year earlier. The 17-point shift isnot gradual drift. It is capital chasing deployment.

The FederalReserve H.4.1 release confirms the macro backdrop. Reserve balances contracted8% quarter-over-quarter as the Fed continued balance-sheet runoff, but bankcommercial and industrial lending held flat at $2.71T. Private credit absorbedthe marginal demand banks did not want to hold on balance sheet. That is themechanic behind the deployment number.

Wherethe risk actually sits

Across ouradvisory work in 2025 and 2026, we observe a specific pattern in thegrowth-stage debt conversations reaching us. Founders with $15M to $50M ARR andburn multiples above 1.5x are receiving term sheets that price cleanly butstructure aggressively. The headline coupon looks reasonable. The maintenancecovenant tests, the cash sweep triggers, and the equity cure limitations do theactual work.

The OECD Q1 2026Lending Standards report frames the same pattern at the aggregate level.Non-bank lender surveys show 38% of respondents loosened structural terms in Q1to win deals, against 21% who loosened pricing. Structure is the concessionlever, not price. That distinction matters for founders who read term sheets bythe coupon and stop.

Bloomberg DCMdata for Q1 2026 shows leveraged loan issuance at $198B, running 22% ahead ofQ1 2025. The refinancing wave is real. Roughly $410B of leveraged loans maturebetween Q3 2026 and Q4 2027 (S&P LCD Maturity Wall, March 2026). Sponsorsare pulling maturity forward while spreads compress. Founders raising freshgrowth debt are pricing into that refinancing supply.

TheQ2 forward view

Three variablesmove Q2 credit pricing. The first is Fed policy path. Treasury futures pricedin 42 basis points of cuts across the June and July meetings as of the March 31close (Federal Reserve H.4.1, CME FedWatch). If the cuts land, private creditspreads compress another 30 to 50 basis points from the Q1 level. If the cutspush to September, the compression pauses and structure loosens further tocompensate.

The second isfund dry powder. PitchBook counts $412B in private credit dry powder as ofMarch 31, of which $178B sits with vehicles raised in 2023 and 2024 that facedeployment pressure. Vintage-year deployment mechanics push that capital intothe market whether the pricing warrants it or not. Expect Q2 deployment volumeto hold above $80B on that mechanic alone.

The third is theLP feedback loop. Carta's Q1 2026 State of Private Markets shows LP allocationintent to private credit at 24% of new commitments, down from a 2024 peak of29%. LP fatigue is real but slow-moving. The rotation shows up in 2027fundraising, not Q2 deployment.

Whatgrowth-stage founders should do

Founders raisinggrowth debt in Q2 should run three specific checks before signing. Pull themaintenance covenant cushion against the 2027 revenue plan and stress it at 70%of plan. If the cushion breaks at 70%, the term sheet is priced for the goodcase and structured for the bad one. That combination is what triggers workoutsin Q4 2027.

Read the cashsweep trigger against the fixed charge coverage ratio, not against EBITDA. Cashsweeps priced on EBITDA multiples look manageable at 2.5x. The same sweeppriced on FCCR at 1.15x is a different instrument. Lenders are increasinglyusing the second definition in 2026 vintage documents. The distinction isburied in the credit agreement, not the term sheet.

Yanne Capital isan independent boutique investment bank advising growth-stage companies onequity, debt, and M&A transactions across 26 sectors, with 240+ closeddeals and relationships with 3,500+ institutional investors globally. We areyour trusted filter between noise and signal. The credit market in Q2 willreward founders who read structure before pricing. It will punish the ones whodo the reverse.

If you areevaluating a growth debt facility in Q2 2026, or refinancing into the 2027maturity wall, reach out at contact@yannecapital.com. We will read the creditagreement with you before you sign it.